Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 9Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 116Lymphoid 44Other hematologic neoplasm 29Thoracic 12Genitourinary 8Gastrointestinal 6CNS 6Breast 6Head & Neck 5Myeloid 3Tumor-Agnostic 2Other solid neoplasm 2Gynecologic 2Endocrine 2Dermatologic 2Sarcoma 1NET 1

Conditions

Uveal Melanoma 1Melanoma 1Macular Edema 1Glioblastoma 1Carcinoma, Medullary 1

Interventions

pembrolizumab 58Cyclophosphamide 53Ipilimumab 52Nivolumab 44aldesleukin 35Interleukin-2 26fludarabine phosphate 22fludarabine 21Vemurafenib 20Temozolomide 19Radiotherapy 18dabrafenib 15trametinib 12Radiosurgery 11CTLA-4 Antigen 11Filgrastim 10Dacarbazine 10spartalizumab 9cobimetinib 9binimetinib 9atezolizumab 9Biopsy 9poly ICLC 8Paclitaxel 8Antilymphocyte Serum 8encorafenib 7avelumab 7Rituximab 7Introns 7romidepsin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Dexamethasone × Dermatologic × Clear all
NCT02709889 2020-10-19

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

AbbVie

Phase 1/2 Terminated
200 enrolled 21 charts
CNSDermatologic

Glioblastoma, Melanoma, Carcinoma, Medullary

NCT01471054 2019-09-03

Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

Wills Eye

Phase 2 Terminated
6 enrolled 10 charts
Dermatologic

Uveal Melanoma, Macular Edema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡